K223592: Advanix™ Pancreatic Stent and NaviFlex™ Rapid Exchange (RX) Pancreatic Delivery System and Pushers (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K223592 (Advanix™ Pancreatic Stent and NaviFlex™ Rapid Exchange (RX) Pancreatic Delivery System and Pushers, cleared 2022-12-29 for Boston Scientific Corporation) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K223592
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK223592
Cleared Device Trade / Generic NameAdvanix™ Pancreatic Stent and NaviFlex™ Rapid Exchange (RX) Pancreatic Delivery System and Pushers
FDA Applicant on FilingBoston Scientific Corporation
FDA 3-Letter Product ClassificationProduct Code FGE
FDA Substantial Equivalence Decision Date2022-12-29
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Boston Scientific across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Boston Scientific Corporation, compare peer devices under FDA Product Code FGE, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.